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Abstract
It is known that L-ascorbic acid (vitamin C) can modulate many biochemical processes intracellularly or 
extracellularly as antioxidant. The aim of the present study was to examine the effects of media supplementation 
with ascorbic acid on canine oocyte meiotic maturation, viability and the cumulus cell expansion. Various 
concentrations of ascorbic acid supplemented in in vitro maturation (IVM) media were tested. Canine oocyte was 
exposed to different levels of ascorbic acid (0, 50, 150, 250, 500, 750µM). Cumulus expansion, meiotic maturation 
and degeneration of oocytes were assessed 72 h after in vitro culture. As results, on the group treated with 250µM 
ascorbic acid was a significant difference compared to the control group on nuclear maturation in stages metaphase 
I (MI) and metaphase II (MII) (26.98% vs. 6.00%). The groups treated with 50, 150, 250, 500µM had an increase 
in stage (GVBD), and a significant decrease of degenerate-undefined oocytes compared with the control (23.31%, 
18.85%, 13.41% vs 40.80). Concentration 750µM had similar effect to that in the control group. The groups treated 
with 50, 150, 250, 500µM had an increase in meiosis resumption (GVBD), metaphase I (MI) and metaphase II (MII) 
with the best result in the group treated with 250 µM ascorbic acid.
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INTRODUCTION 
The development of in vitro techniques using 
the canine oocyte as an experimental model would 
retain powerful tools for gamete rescue programs, 
which are important to preserve the existence of 
various endangered canid species (Hewitt and 
England, 2001; Otoi et al., 2002), as a model for 
studying human genetic disorders. Domestic dogs 
exhibit spontaneous occurrence of cancers, and as 
pets, they are exposed to environmental factors 
common to humans (Davis and Ostrander, 2014; 
Switonski, 2014). The 350 traits/disorders 
identified in the dog with potential to be models 
for human disease is almost twice that of any other 
species (Nicholas, 2003).
Development of assisted reproductive 
technologies (ART) in the dog has resisted progress 
for decades, due to their unique reproductive 
physiology. The oocyte of the domestic dog is 
unique from that of other mammalian species 
studied to date. Ovulation occurs either once 
or twice per year, with the oocyte released at 
the germinal vesicle stage and then completing 
nuclear and cytoplasmic maturation within the 
oviduct, and requires 48–72 h in the oviduct 
post-ovulation to complete nuclear maturation 
(Reynaud et al., 2005). From 1976 (Mahi and 
Yanagimaci, 1976) to date, numerous studies have 
been conducted to improve success of in vitro 
maturation (IVM) of bitch oocytes but an efficient 
protocol for IVM has not been established. In 
vitro maturation, generally has resulted in low 
rates of successful resumption of meiosis, with 
the exception being one study that found that use of oocytes from follicles larger than 2 mm 
yielded significantly higher rates of metaphase 
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II development in vitro (Songsasen and Wildt, 
2005), where 79.5% of oocytes recovered from 
follicles 2 mm size reached the second metaphase 
(MII), usually less than 20% of canine oocytes 
achieve nuclear maturation (Songsasen and Wildt, 
2007). Moreover, only a single blastocyst has been 
produced   after   in   vitro   fertilization   of   in vitro 
matured oocytes (Otoi et al., 2000). 
Age of the donor bitch (Hewitt and England, 
1998; Songsasen et al., 2002), stage of the 
reproductive cycle (Yamada et al., 1993; Otoi et 
al., 2001), oocyte diameter (Otoi et al., 2000;  Ariu 
et al., 2011), and the size of the ovarian follicle 
(Songsasen and Wildt, 2005) are factors influencing 
meiotic   competence   of   bitch   oocytes   cultured 
in vitro. In particular, oocyte diameter may be a 
useful selection parameter. It has been reported 
(Otoi et al., 2000) that large oocytes (>120 µm 
diameter) had a higher frequency of maturation 
than oocytes (<110 µm diameter). This result 
also suggests the importance of selecting good 
quality of cumulus-oocyte complexes (COCs) by 
morphological appearance for IVM of oocytes. 
Low maturation rates could be due to either 
suboptimal culture conditions or low meiotic 
competence of the oocytes (Farstad, 2000). 
Vitamins are indispensable nutrients involved 
in a variety of multiple cell functions and they 
are also essential for mammalian reproduction 
(Meister and Tate, 1976; Hurley and Doane, 1989). 
They function not only as cellular antioxidants, but also as modulators of many intracellular or 
extracellular biochemical processes. Ascorbic 
acid (vitamin C) is functional in many biological 
processes such as the biosynthesis of collagen 
and other components of the extracellular 
matrix and is the most important antioxidant in 
extracellular fluids (Buettner, 1993). Predominant 
in preovulatory follicles in rat ovaries (Guarnaccia 
et al., 2000), ascorbic acid   prevents follicular 
apoptosis in cultured rat (Tilly and Tilly, 1995) 
and mouse follicles (Eppig et al., 2000). Ascorbic 
acid enhances   porcine oocyte developmental 
competence (Tatemoto et al., 2001) and prevents 
the apoptosis of granulosa cells (Murray et al., 
2001) and ovarian follicular cells (Tilly and Tilly, 
1995). Few systematic studies have investigated the function of ascorbic acid on oocyte in vitro 
maturation. The aim of the present study was to 
examine the effects of media supplementation 
with various concentrations (0, 50, 150, 250, 500, 
750µM) of ascorbic acid on canine oocyte meiotic maturation in vitro.  
MATERIALS AND METHODS 
All the chemicals used in this study were pur-
chased from Sigma-Aldrich (USA). To investigate 
the effect of ascorbic acid for improving oocyte maturation, in vitro maturation (IVM) TCM-199 
medium was supplemented with five concentra-
tions 50, 150, 250, 500, 750µM acid ascorbic dur-ing 72 h in vitro culture. 
Reproductive tracts from normal bitches 
greater than 6 months of age of different breeds and 
at various stages of their estrus cycle, were collected 
after routine ovariohysterectomy at private clinics, 
placed immediately into physiological saline 
solution at 37°C supplemented with penicillin G 
and streptomycin   sulfate, and transported back to 
the laboratory within 1 h. Ovaries were removed 
from the tract and washed free from blood in fresh 
physiological saline solution. 
Cumulus–oocyte complexes (COCs) were 
released by slicing the ovarian cortex with a 
scalpel blade; oocytes were washed in the bench 
medium to wash of blood and other debris prior to 
transfer to maturation medium. Cumulus–oocyte 
complexes (COCs) which has compact and more 
than three layers of cumulus cells, dark oocyte 
cytoplasm were selected (Hewitt and England, 
1998) and transferred in IVM medium containing 
TCM-199 supplemented with sodium pyruvate, 
fetal bovine serum (FBS) 10 %, Folligon (10 IU/ml), 
Chorulon (10 IU/ml), β-estradiol and antibiotics 
(penicillin, streptomycin, gentamicin) under 
paraffin oil for 72 h at 37°C (Luvoni et al., 2001) in 
an atmosphere of 5% CO2 and 95% air humidity. To investigate the effect various concentrations of 
ascorbic acid were tested 0.0 (control), 50, 150, 
250, 500 and 750µM.At the end of the maturation culture, oocytes 
were completely denuded by gently pipetting 
with phosphate buffer saline (PBS) and 0.1% 
PVA. After 72 h of in vitro culture, oocytes were evaluated for viability and nuclear meiotic stage 
under fluorescence microscopy (Olympus IX 51) 
with UV light. The effect of ascorbic acid on the 
percentages of oocytes reaching various stages 
of nuclear maturation compared to the control 
and the differences analyzed using the analysis 
of variance and interpreted using the Tukey test 
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and the IBM SPSS software.  Differences of P < 0.05 
were considered significant.
RESULTS AND DISCUSSION 
COCs were obtained by slicing the ovarian 
cortex from bitches at various stages of their 
estrus cycle. The progression of meiosis was 
evaluated after staining with propidium iodide 
under fluorescence microscopy and the data are 
summarized in (Table 1). Results demonstrated 
that incubation with 50, 150, 250 or 500µM 
ascorbic acid showed a decrease in the   proportion of oocytes that remained at the germinal vesicle 
stage (GV) compared to the   control group. 
The percentage of GVBD oocytes in the 750µM 
(15.21%) group was similar to that in the control 
group (18.78%), but a significantly higher 
proportion was in the 250µM group (P<0.05) 
The percentage of oocytes reaching MI/MII 
stage was significantly higher after   incubation 
with 150 or 250µM ascorbic acid (P<0.001, 
23.61% or 26.98%) compared with the control 
group (6.00%) and the incubation with 250µM 
was significantly higher (p<0.05) compared with 
the other groups. The groups treated with 50, 150, 
250µM had a significantly decrease of degenerate-
undefined oocytes compared with the control 
(23.31%, 18.85%, 13.41% vs 40.80) and the group 
treated with the 750µM had similar effect to that 
in the control group.
Dog oocytes, like those of other species, are able to resume meiosis in vitro, but are not fully 
competent to complete nuclear maturation. 
From 1976 (Mahi and Yanagimaci, 1976) to date, numerous studies have been conducted to 
improve success of in vitro maturation (IVM) of 
bitch oocytes but an efficient protocol for IVM has 
not been established.  
The influence of various factors on the in vitro maturation of canine oocytes such as age of the 
donor bitch (Hewitt and England, 1998; Songsasen 
et al., 2002) the stage of the reproductive cycle 
(Yamada et al., 1993; Otoi et al., 2001), oocyte 
diameter (Ariu et al., 2011; Otoi et al., 2000), 
the size of the ovarian follicle (Songsasen and 
Wildt, 2005) using hormonal supplementation 
(Apparicio et al., 2011) have been tested to 
improve canine IVM system. Nevertheless, efforts 
to assess various factors have provided a lot of valuable information for the advancement of 
canine IVM system.  Some investigators have 
indicated no association on the relationship 
between stage of reproductive cycle and oocyte 
meiotic competence (Hossein et al., 2007; Otoi et 
al., 2002; Songsasen and Wildt, 2005) whereas 
others have demonstrated that reproductive 
cycle stage significantly impacts developmental 
capacity of the oocyte (Yamada et al., 1993; Otoi 
et al., 2001; Luvoni et al., 2001; Kim et al., 2004). 
In the present study, higher proportion of oocytes 
reached MI and MII stage in the presence of 
ascorbic acid at certain concentrations compared 
to those in the control group. It has been shown 
that ascorbic acid protects cells from oxidative 
stress and improve maturation on mouse oocytes 
(Eppig et al., 2000). 
Predominant in preovulatory follicles in 
rat ovaries (Guarnaccia et al., 2000) ascorbic 
acid   prevents follicular apoptosis in cultured rat 
(Tilly and Tilly, 1995) enhanced porcine oocyte 
developmental competence (Tatemoto et al., 2001; Miclea et al., 2012), improved the suboptimal 
culture conditions for porcine parthenotes and 
Tab. 1. Meiotic status of canine oocytes cultured in TCM-199 supplemented with ascorbic acid 
Concentrations (µM)
Number ofoocytes %nuclear status of oocytes (mean ± SD)
GV GVBD MI/MII DEG/UND
0 53 34.40±9.99 18.79±10.34a 6.01±5.97a 40.81±9.06a
50 54 27.65±6.08 32.89±9.92 16.15±8.86 23.31±8.39b
150 55 27.57±6.05 29.96±10.17 23.61±1.96b 18.85±8.82b
250 57 24.01±3.46 35.59±8.35b 26.99±6.79b 13.42±8.15b
500 55 28.31±9.16 31.16±10.28 13.92±6.90 26.61±13.24
750 52 35.17±9.33 15.22±11.01 8.87±7.26 40.75±13.26
GV, germinal vesicle; GVBD, germinal vesicle break down; MI/MII metaphase I/II; DEG/UND, degenerate/undefined oocytes. Different 
superscript within the same column indicate a significant difference a  vs b  P< 0.05.
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cloned embryos (Kere et al., 2013) and prevents the 
apoptosis of granulosa cells (Murray et al., 2001) 
and ovarian follicular cells (Tilly and Tilly, 1995). 
The results of this study showed that ascorbic 
acid increases meiotic resumption of canine 
oocytes. The highest percentage of maturation to 
MI/MII stage was in the groups treated with 150 
or 250µM ascorbic acid, but it also impose some side effects by decreasing the maturation rate at 
750 µM. That may be because ascorbic acid has 
two different actions: an antioxidant action at 
lower concentrations, and a pro-oxidant action 
at higher concentrations (Tatemoto et al., 2001). Our results suggest that ascorbic acid increases 
meiotic resumption of canine oocytes at certain 
concentrations. The highest rate of maturation to 
metaphase I/II stage was obtained after treatment 
of oocytes with 250µM. This is similar to work 
of other authors (Tao et al., 2004; Tatemoto et 
al., 2001; Eppig et al., 2000). In canine species 
recent reports also showed that addition of 
β-mercaptoethanol (β-ME) (Kim et al., 2004), 
cysteine and cysteamine (Hossein et al., 2007), 
polyether fatty acid, okadaic acid (Ariu et al., 2011), 
9-cis retinoic acid (Liang et al., 2012) to IVM media 
improved meiotic competence of oocytes.In conclusion, the addition of ascorbic acid 
at certain concentration (250µM) to the in vitro maturation system of canine oocytes increases 
meiotic resumption and maturation rates to MI/
MII. 
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